Successful treatment of pityriasis rubra pilaris with risankizumab, a IL-23/p19 antagonist
Related Experiment Video
Updated: Aug 14, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.0K
Anne-Laure Fouarge1, Marie Cuvelier1, Charlotte Roquet-Gravy1
1Division of Dermatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
Abstract
No abstract available in PubMed .

